J Neurochem 73:390399 Kannan R, Yi JR, Tang D, Li Y, Zlokovic BV, Kaplowitz N (1996) Evidence for the existence of a sodium-dependent glutathione (GSH) transporter
52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA
Note: These higher doses are typically used for specific periods and should be discussed with a healthcare professional, especially if you plan to stay at that level for more than a few months
Product Description Compound Specifications Full Name: Glycyl-L-Histidyl-L-Lysine Copper Peptide Abbreviation: GHK-Cu Sequence Type: Copper-binding tripeptide complex Amino Acid Sequence: GlyHisLys Molecular Formula: CHCuNO Molecular Weight: ~340.9 g/mol CAS Number: 89030-95-5 Structure Notes: Naturally occurring copper-binding peptide complex studied for its role in cellular communication, dermal signaling environments, and structural protein regulation Overview GHK-Cu is a naturally occurring copper-binding peptide complex frequently incorporated into experimental models examining how peptide-mediated signaling influences cellular communication , structural protein environments , and dermal signaling behavior
doi: 10.1371/journal.pone.0062409 248